963
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?

, ORCID Icon, , , &
Article: 2217295 | Received 22 Jun 2022, Accepted 18 May 2023, Published online: 29 May 2023

Figures & data

Figure 1. Control group; (A) Endometrium, endometrial stromal cell (black arrow) (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained endothelial cell (yellow arrow); VEGFR-2 immunostained epithelial cell (blue arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).

Figure 1. Control group; (A) Endometrium, endometrial stromal cell (black arrow) (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained endothelial cell (yellow arrow); VEGFR-2 immunostained epithelial cell (blue arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).

Figure 2. OHSS-placebo group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).

Figure 2. OHSS-placebo group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).

Figure 3. Cabergoline group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).

Figure 3. Cabergoline group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).

Table 1. A comparison of weight gain, ovarian volume, corpora lutea numbers, and numbers of endometrial VEGFR-2 stained cells between the groups.